Circulating MicroRNAs in Idiopathic Pulmonary Fibrosis
Author Information
Author(s): Colin Waldo Marisa Denisse, Quintero-Millán Xochipilzihuitl, Negrete-García Maria Cristina, Ruiz Víctor, Sommer Bettina, Romero-Rodríguez Dámaris P., Montes-Martínez Eduardo, Chen Liang
Primary Institution: National Institute of Respiratory Diseases “Ismael Cosío Villegas”, Mexico City, Mexico
Hypothesis
The review analyzes the role of circulating microRNAs as potential biomarkers in idiopathic pulmonary fibrosis (IPF).
Conclusion
Circulating microRNAs, particularly let-7d and miR-21, show promise as biomarkers for diagnosing and understanding the progression of IPF.
Supporting Evidence
- Circulating miRNAs have been shown to be adequate biomarkers for idiopathic pulmonary fibrosis.
- miR-21 levels correlate with clinical and radiological variables in IPF patients.
- Let-7d and let-7a are downregulated in IPF, indicating their potential role in disease progression.
Takeaway
This study looks at tiny molecules in the blood that might help doctors figure out if someone has a serious lung disease called idiopathic pulmonary fibrosis.
Methodology
The review summarizes existing literature on serum/plasma microRNAs in IPF, focusing on those validated by real-time PCR.
Limitations
The review does not cover long non-coding RNAs and lacks comparative studies between IPF and other interstitial lung diseases.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website